His primary areas of study are Cell biology, Molecular biology, Cell adhesion molecule, Endothelial stem cell and Biochemistry. His Cell biology study combines topics in areas such as Integrin, Cell adhesion and Binding site. His research in Molecular biology intersects with topics in Antigen, Complementary DNA, Peptide sequence, Protein structure and Oligonucleotide.
The concepts of his Cell adhesion molecule study are interwoven with issues in Neural cell adhesion molecule and Cell junction. His studies in Endothelial stem cell integrate themes in fields like Receptor, CD31 and Pathology. His Biochemistry study frequently draws connections between related disciplines such as Platelet.
Peter J. Newman mostly deals with Cell biology, Platelet, Molecular biology, Biochemistry and Immunology. His Cell biology research is multidisciplinary, relying on both Endothelial stem cell, Integrin and Cell adhesion. He works mostly in the field of Endothelial stem cell, limiting it down to concerns involving CD31 and, occasionally, Inflammation.
Peter J. Newman has researched Platelet in several fields, including Receptor and Glycoprotein. His Molecular biology study also includes fields such as
His main research concerns Cell biology, Platelet, Immunology, Molecular biology and Neonatal alloimmune thrombocytopenia. His Cell biology research is multidisciplinary, incorporating elements of Endothelial stem cell, Receptor, Biochemistry, Cell junction and Cell adhesion. His Cell adhesion research is multidisciplinary, incorporating perspectives in Vasculogenesis and CD31.
His biological study spans a wide range of topics, including Integrin and Induced pluripotent stem cell. The various areas that he examines in his Molecular biology study include Plasmid, Membrane anchoring and Platelet transfusion refractoriness. His Neonatal alloimmune thrombocytopenia study also includes
Peter J. Newman mainly focuses on Cell biology, Endothelial stem cell, Platelet, Vascular permeability and Cell adhesion. His study in Cell biology is interdisciplinary in nature, drawing from both HEK 293 cells and Cell junction. His study connects Cell adhesion molecule and Cell junction.
His Platelet study is concerned with the field of Immunology as a whole. His Immunology research integrates issues from Molecular biology and Neonatal alloimmune thrombocytopenia. His Vascular permeability research includes elements of Barrier function and CD31.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily
Peter J. Newman;Michael C. Berndt;Jack Gorski;Gilbert C. White.
Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.
Steven M. Albelda;William A. Muller;Clayton A. Buck;Peter J. Newman.
Journal of Cell Biology (1991)
The biology of PECAM-1.
P J Newman.
Journal of Clinical Investigation (1997)
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
P J Newman;R S Derbes;R H Aster.
Journal of Clinical Investigation (1989)
Integrins: dynamic scaffolds for adhesion and signaling in platelets.
Sanford J. Shattil;Peter J. Newman.
Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.
J N George;E B Pickett;S Saucerman;R P McEver.
Journal of Clinical Investigation (1986)
CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.
Y Tanaka;S M Albelda;K J Horgan;G A van Seventer.
Journal of Experimental Medicine (1992)
Signal Transduction Pathways Mediated by PECAM-1: New Roles for an Old Molecule in Platelet and Vascular Cell Biology
Peter J. Newman;Debra K. Newman.
Arteriosclerosis, Thrombosis, and Vascular Biology (2003)
Molecular and functional aspects of PECAM-1/CD31.
Horace M. DeLisser;Peter J. Newman;Peter J. Newman;Steven M. Albelda.
Immunology Today (1994)
Nomenclature of human platelet antigens.
P. Metcalfe;N. A. Watkins;W. H. Ouwehand;W. H. Ouwehand;C. Kaplan.
Vox Sanguinis (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: